Anakinra in Adults With Severe COVID-19 and Features of Cytokine Storm Syndrome: A Randomized, Double-blind, Placebo-controlled Trial
Latest Information Update: 31 Jan 2022
At a glance
- Drugs Anakinra (Primary)
- Indications COVID 2019 infections; COVID-19 pneumonia; Cytokine release syndrome; Respiratory insufficiency
- Focus Therapeutic Use
- Acronyms SOBI
- 14 Jan 2022 Status changed from not yet recruiting to withdrawn prior to enrolment because the funding did not go through.
- 26 Aug 2021 Planned End Date changed from 1 Feb 2022 to 1 Sep 2022.
- 26 Aug 2021 Planned primary completion date changed from 1 Dec 2021 to 1 Jun 2022.